scispace - formally typeset
P

Pia Munkholm

Researcher at University of Copenhagen

Publications -  209
Citations -  19113

Pia Munkholm is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Inflammatory bowel disease & Ulcerative colitis. The author has an hindex of 65, co-authored 195 publications receiving 17166 citations. Previous affiliations of Pia Munkholm include Herlev Hospital & Royal Adelaide Hospital.

Papers
More filters
Journal ArticleDOI

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

TL;DR: Evidence- and consensus-based recommendations for selecting the goals for treat-to-target strategies in patients with IBD are made available and future studies are needed to determine how these targets will change disease course and patients’ quality of life.
Journal ArticleDOI

Familial Occurrence of Inflammatory Bowel Disease

TL;DR: The 10-fold increase in the familial risk of ulcerative colitis and Crohn's disease strongly suggests that these disorders have a genetic cause.
Journal ArticleDOI

Course of ulcerative colitis: Analysis of changes in disease activity over years

TL;DR: About half of patients with UC will be in remission at any time, although 90% have an intermittent course, and relapses are unpredictable except that disease activity in foregoing years indicates with 70%-80% probability that the disease will continue the following year.
Journal ArticleDOI

Frequency of glucocorticoid resistance and dependency in Crohn's disease.

TL;DR: Localisation of disease, age, sex, sex or clinical symptoms did not significantly correlate with outcome, which can be summarised as prolonged steroid response in 44%, steroid dependency in 36%, and steroid resistant in 20% of the patients.
Journal ArticleDOI

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease

TL;DR: Although colorectal cancer (CRC), complicating ulcerative colitis and Crohn's disease, only accounts for 1–2% of all cases of CRC in the general population, it is considered a serious complication of the disease and accounts for approximately 15% ofall deaths in inflammatory bowel disease patients.